Is a complete SRPT research report available?

No complete published report is available for Sarepta Therapeutics, Inc. (SRPT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · USD

$19.3

+0.41 (+2.2%)· Recorded snapshot

Market cap	2B
Revenue (ttm)	2B
Net income (ttm)	-136.7M
EPS (ttm)	-$1.32
Shares out	105.6M
P/E (forward)	84.9x
Volume	1,054,258
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2B
Net income (ttm): -136.7M
EPS (ttm): -$1.32
P/E (forward): 84.9x
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0000873303
Company name	Sarepta Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	803607100
Earnings date	2026-11-05
Earnings time	amc
Employees	835
Employees change	-537
Employees growth	-39.14%
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1980
In index	RUSSELL2000
Industry	Biotechnology
IPO date	1997-06-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US8036071004
Last 10-K release date	2026-03-02
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2012-07-12
Last stock split type	Reverse
Market cap	$2B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$19.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	SRPT
U.S. state	Massachusetts
Website	https://www.sarepta.com

Metric

Value

Amount currency

USD

CIK code

0000873303

Company name

Sarepta Therapeutics, Inc.

Country

United States

Country code

CUSIP number

803607100

Earnings date

2026-11-05

Earnings time

amc

Employees

835

Employees change

-537

Employees growth

-39.14%

Enterprise value

$2.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1980

In index

RUSSELL2000

Industry

Biotechnology

IPO date

1997-06-03

Is primary listing

Yes

Is SPAC

ISIN number

US8036071004

Last 10-K release date

2026-03-02

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2012-07-12

Last stock split type

Reverse

Market cap

$2B

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$19.30

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

SRPT

U.S. state

Massachusetts

Website

https://www.sarepta.com

Metric	Value
Adjusted P/E ratio	214.44x
Earnings yield	-6.82%
EV/FCF	27.87x
EV/Sales	1.16x
FCF / EV yield	3.59%
FCF yield	4.08%
Forward EV/Sales	1.63x
Forward P/E	84.94x
Forward P/S	1.43x
P/(OCF - SBC) ratio	164.63x
P/B ratio	1.31x
P/FCF ratio	24.53x
P/OCF ratio	18.08x
P/S ratio	1.02x
Price / tangible book value	1.34x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Adjusted P/E ratio

214.44x

Earnings yield

-6.82%

EV/FCF

27.87x

EV/Sales

1.16x

FCF / EV yield

3.59%

FCF yield

4.08%

Forward EV/Sales

1.63x

Forward P/E

84.94x

Forward P/S

1.43x

P/(OCF - SBC) ratio

164.63x

P/B ratio

1.31x

P/FCF ratio

24.53x

P/OCF ratio

18.08x

P/S ratio

1.02x

Price / tangible book value

1.34x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
EBIT margin	-3.15%
EBITDA margin	-0.89%
FCF margin	4.15%
Gross margin	19.11%
Operating margin	-3.15%
Pretax margin	-6.63%
Profit margin	-6.93%
Profit per employee	$-163,743
Revenue per employee	$2.4M
ROA	-1.13%
ROA (5Y)	-6.49%
ROCE	-2.32%
ROE	-9.48%
ROE (5Y)	-55.33%
ROIC	-3.36%
SBC / revenue	5%
Tax / revenue	0.29%

Metric

Value

EBIT margin

-3.15%

EBITDA margin

-0.89%

FCF margin

4.15%

Gross margin

19.11%

Operating margin

-3.15%

Pretax margin

-6.63%

Profit margin

-6.93%

Profit per employee

$-163,743

Revenue per employee

$2.4M

ROA

-1.13%

ROA (5Y)

-6.49%

ROCE

-2.32%

ROE

-9.48%

ROE (5Y)

-55.33%

ROIC

-3.36%

SBC / revenue

Tax / revenue

0.29%

Metric	Value
EPS growth years	0
FCF growth (Q)	-14.39%
Gross profit growth	-33.24%
Gross profit growth (Q)	-36.8%
Net income growth years	0
OCF growth (Q)	-24.59%
Operating income growth (Q)	-54.76%
Revenue growth	-20.44%
Revenue growth (Q)	-34.34%
Revenue growth (QoQ)	-45.09%
Revenue growth 10Y	108.81%
Revenue growth 3Y	25.31%
Revenue growth 5Y	26.89%
Revenue growth years	10

Metric

Value

EPS growth years

FCF growth (Q)

-14.39%

Gross profit growth

-33.24%

Gross profit growth (Q)

-36.8%

Net income growth years

OCF growth (Q)

-24.59%

Operating income growth (Q)

-54.76%

Revenue growth

-20.44%

Revenue growth (Q)

-34.34%

Revenue growth (QoQ)

-45.09%

Revenue growth 10Y

108.81%

Revenue growth 3Y

25.31%

Revenue growth 5Y

26.89%

Revenue growth years

Metric	Value
Capital expenditures	$-29.2M
Depreciation and amortization	$44.7M
EBIT	$-62.2M
EBITDA	$-17.5M
EPS	$-1.32
FCF per share	$0.77
Financing cash flow	$-156.8M
Free cash flow	$81.8M
Free cash flow minus SBC	$-17M
Gross profit	$377.3M
Income taxes	$5.8M
Investing cash flow	$100.8M
Net borrowing	$-159.1M
Net cash flow	$55.1M
Net income	$-136.7M
Operating cash flow minus SBC	$12.2M
Operating income	$-62.2M
Revenue	$2B
Stock-based compensation	$98.8M

Metric

Value

Capital expenditures

$-29.2M

Depreciation and amortization

$44.7M

EBIT

$-62.2M

EBITDA

$-17.5M

EPS

$-1.32

FCF per share

$0.77

Financing cash flow

$-156.8M

Free cash flow

$81.8M

Free cash flow minus SBC

$-17M

Gross profit

$377.3M

Income taxes

$5.8M

Investing cash flow

$100.8M

Net borrowing

$-159.1M

Net cash flow

$55.1M

Net income

$-136.7M

Operating cash flow minus SBC

$12.2M

Operating income

$-62.2M

Revenue

$2B

Stock-based compensation

$98.8M

Metric	Value
Altman Z-Score	-0.07
Book value per share	$14.46
Debt / EBITDA	7.07
Debt / equity	0.7
Debt / FCF	12.98
Interest coverage	-0.87
Long-term assets	$964.7M
Long-term liabilities	$1.2B
Net cash (debt)	$-273.9M
Net cash / market cap	-13.65%
Net debt / equity	0.18
Net debt / FCF	3.35
Piotroski F-Score	4
Property, plant and equipment	$446.8M
Shareholders' equity	$1.5B
Tangible book value	$1.5B
Tangible book value per share	$14.17
Total assets	$3.2B
Total cash	$788.5M
Total debt	$1.1B
Total liabilities	$1.7B
WACC	5.97%

Metric

Value

Altman Z-Score

-0.07

Book value per share

$14.46

Debt / EBITDA

7.07

Debt / equity

0.7

Debt / FCF

12.98

Interest coverage

-0.87

Long-term assets

$964.7M

Long-term liabilities

$1.2B

Net cash (debt)

$-273.9M

Net cash / market cap

-13.65%

Net debt / equity

0.18

Net debt / FCF

3.35

Piotroski F-Score

Property, plant and equipment

$446.8M

Shareholders' equity

$1.5B

Tangible book value

$1.5B

Tangible book value per share

$14.17

Total assets

$3.2B

Total cash

$788.5M

Total debt

$1.1B

Total liabilities

$1.7B

WACC

5.97%

Metric	Value
Asset turnover	0.57
Current assets	$2.2B
Current liabilities	$502.9M
Current ratio	4.42
Inventory turnover	1.68
Net working capital	$949M
Quick ratio	2.44
Working capital	$1.7B
Working capital turnover	1.14

Metric

Value

Asset turnover

0.57

Current assets

$2.2B

Current liabilities

$502.9M

Current ratio

4.42

Inventory turnover

1.68

Net working capital

$949M

Quick ratio

2.44

Working capital

$1.7B

Working capital turnover

1.14

Metric	Value
Buyback yield / dilution	-7.36%
Dividend yield	0%
Shareholder yield	-7.36%

Metric

Value

Buyback yield / dilution

-7.36%

Dividend yield

Shareholder yield

-7.36%

Metric	Value
10Y price change	-53.57%
10Y return CAGR	-7.39%
10Y total return	-53.57%
150-day SMA	$18.74
15Y price change	206.63%
15Y return CAGR	7.76%
15Y total return	206.63%
1D price change	2.17%
1M price change	1.5%
1M total return	1.5%
1W price change	-1.15%
1W total return	-1.15%
1Y price change	-19.36%
1Y return CAGR	-19.37%
1Y total return	-19.36%
20-day SMA	$17.82
200-day SMA	$18.75
20Y price change	-23.71%
20Y return CAGR	-1.34%
20Y total return	-23.71%
3M price change	19.26%
3M total return	19.26%
3Y price change	-82.26%
3Y return CAGR	-43.81%
3Y total return	-82.26%
50-day SMA	$19.26
50-day SMA vs 200-day SMA	50over200
52-week high	$24.68
52-week high date	2026-01-26
52-week low	$14.68
52-week low date	2026-06-11
5Y price change	-75.48%
5Y return CAGR	-24.51%
5Y total return	-75.48%
6M price change	-9.68%
6M total return	-9.68%
All-time high	$181.83
All-time high date	2020-12-22
All-time low	$2.60
All-time low date	2012-05-18
Average true range (ATR)	$0.97
Average volume	2.9M
Beta (1Y)	2.27
Beta (2Y)	1.39
Beta (5Y)	0.38
Change from 52-week high	-21.8%
Change from 52-week low	31.47%
Change from all-time high	-89.58%
Change from all-time low	628.85%
Change from open	3.49%
Day's gap	-1.27%
Dollar volume	$20.3M
High price	$19.31
Low price	$18.65
Monthly RSI	33.48
Open price	$18.65
Position in 52-week range	98.48%
Premarket change	-1.85%
Premarket close	$18.89
Premarket price	$18.54
Premarket volume	37.3K
Previous close	$18.89
Price vs 150-day SMA	1.15%
Price vs 20-day SMA	6.37%
Price vs 200-day SMA	1.05%
Price vs 50-day SMA	-1.59%
Relative volume	0.36
RSI	54.21
Sharpe ratio	0.08
Sharpe ratio (3Y)	-0.33
Sharpe ratio (5Y)	-0.09
Sortino ratio	0.19
Sortino ratio (3Y)	-0.37
Sortino ratio (5Y)	-0.05
Volume	1.1M
Weekly RSI	50.23
YTD price change	-11.94%
YTD total return	-11.94%

Metric

Value

10Y price change

-53.57%

10Y return CAGR

-7.39%

10Y total return

-53.57%

150-day SMA

$18.74

15Y price change

206.63%

15Y return CAGR

7.76%

15Y total return

206.63%

1D price change

2.17%

1M price change

1.5%

1M total return

1.5%

1W price change

-1.15%

1W total return

-1.15%

1Y price change

-19.36%

1Y return CAGR

-19.37%

1Y total return

-19.36%

20-day SMA

$17.82

200-day SMA

$18.75

20Y price change

-23.71%

20Y return CAGR

-1.34%

20Y total return

-23.71%

3M price change

19.26%

3M total return

19.26%

3Y price change

-82.26%

3Y return CAGR

-43.81%

3Y total return

-82.26%

50-day SMA

$19.26

50-day SMA vs 200-day SMA

50over200

52-week high

$24.68

52-week high date

2026-01-26

52-week low

$14.68

52-week low date

2026-06-11

5Y price change

-75.48%

5Y return CAGR

-24.51%

5Y total return

-75.48%

6M price change

-9.68%

6M total return

-9.68%

All-time high

$181.83

All-time high date

2020-12-22

All-time low

$2.60

All-time low date

2012-05-18

Average true range (ATR)

$0.97

Average volume

2.9M

Beta (1Y)

2.27

Beta (2Y)

1.39

Beta (5Y)

0.38

Change from 52-week high

-21.8%

Change from 52-week low

31.47%

Change from all-time high

-89.58%

Change from all-time low

628.85%

Change from open

3.49%

Day's gap

-1.27%

Dollar volume

$20.3M

High price

$19.31

Low price

$18.65

Monthly RSI

33.48

Open price

$18.65

Position in 52-week range

98.48%

Premarket change

-1.85%

Premarket close

$18.89

Premarket price

$18.54

Premarket volume

37.3K

Previous close

$18.89

Price vs 150-day SMA

1.15%

Price vs 20-day SMA

6.37%

Price vs 200-day SMA

1.05%

Price vs 50-day SMA

-1.59%

Relative volume

0.36

RSI

54.21

Sharpe ratio

0.08

Sharpe ratio (3Y)

-0.33

Sharpe ratio (5Y)

-0.09

Sortino ratio

0.19

Sortino ratio (3Y)

-0.37

Sortino ratio (5Y)

-0.05

Volume

1.1M

Weekly RSI

50.23

YTD price change

-11.94%

YTD total return

-11.94%

Metric	Value
Float	100.5M
Float percentage	95.19%
Shares change (QoQ)	-13.52%
Shares change (YoY)	7.36%
Shares held by insiders	4.78%
Shares held by institutions	102.45%
Shares outstanding	105.6M
Short % of float	22.66%
Short % of shares	21.57%
Short ratio	7.8 days

Metric

Value

Float

100.5M

Float percentage

95.19%

Shares change (QoQ)

-13.52%

Shares change (YoY)

7.36%

Shares held by insiders

4.78%

Shares held by institutions

102.45%

Shares outstanding

105.6M

Short % of float

22.66%

Short % of shares

21.57%

Short ratio

7.8 days

Sarepta Therapeutics, Inc. (SRPT)

Price

Financial snapshot

Fair-value bridge

Latest news · SRPT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SRPT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SRPT

Frequently asked questions